News & Events
EME in Spain welcomed as MSIF’s newest member
Esclerosis Múltiple España is now an associate member of the MS International Federation
Not long until World Brain Day – find out what it’s all about
22 July – join the conversation this World Brain Day
FDA backs further research into ‘neurofilament light chain’
The regulatory agency’s Letter of Support will stimulate more studies that advance development and validation of the…
Professor Alan Thompson wins the prestigious MS Charcot Award
Professor Thompson wins the 2021 lifetime achievement award for outstanding research into the understanding and treatment of…
Alliance funds 19 Research Challenge Awards looking for answers on progression
In time for World MS Day, €1,425,000 has been awarded to help identify new therapeutic targets in…
How do different DMTs affect people’s COVID-19 vaccine response?
Researchers in Israel have published the results of a small study exploring how well the Pfizer-BioNtech COVID-19…
Join the movement to stop MS this World Brain Day
Save the date – World Brain Day is on 22 July 2021
MS and depression – testing the relationship
This article delves into the land of genetics, explaining the method called ‘Mendelian randomisation’, which scientists use…
The Atlas of MS part 2 is live!
The clinical management part of the Atlas of MS is now available
Catch up on the latest breakthroughs in progressive MS treatments
A first-of-its-kind global research network funded by the International Progressive MS Alliance aims to develop new, effective…
Celebrating the Spanish language in the global MSIF movement
With over 500 million people across the world who speak Spanish there is an obvious need for…
What is a biomarker?
Biomarkers is a term that often comes up when we talk about MS treatment and clinical trials…